Aqemia Raises €30M to Scale its Deep Physics and AI Enabled Drug Discovery Pipeline
businesswire.com
news
2022-10-19 00:00:00

October 19, 2022 03:35 AM Eastern Daylight Time PARIS--(BUSINESS WIRE)--Aqemia raises €30 million in a Series A funding round led by Eurazeo and Bpifrance through its Large Venture fund, with the participation of Elaia its historic investor. This financing will further support Aqemia's core mission: to massively scale drug discovery, through a first-in-class technological platform combining quantum-inspired physics and machine learning.



In three years, Aqemia has grown from a spin-off of Ecole Normale Superieure to an A-team of 50 people at the crossroads of Chemistry and Artificial Intelligence, and has built its innovation engine - Aqemia's Launchpad.
